GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascendis Pharma AS (BSP:A1SN34) » Definitions » Dividend-Payout-to-FFO

Ascendis Pharma AS (BSP:A1SN34) Dividend-Payout-to-FFO


View and export this data going back to 2020. Start your Free Trial

What is Ascendis Pharma AS Dividend-Payout-to-FFO?

Dividend-Payout-to-FFO only applies to REITs.


Ascendis Pharma AS Business Description

Traded in Other Exchanges
Address
Tuborg Boulevard 12, Hellerup, DNK, DK-2900
Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.